Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Mastercard IncMA · Entity 1763 | Chief Human Resources Officer | April 15, 2016 | April 19, 2016 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Mastercard Inc
Report date April 15, 2016 · Filed April 19, 2016
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Class A Common StockSEC Table I · non-derivative | Direct | 8,602 |
Ending reported balance
After 2016-04-15 transaction · row 2
2 source rows · reconciled sequenceRow 1 · 2016-04-15 · Exercise / conversion · Acquired 5,784 · Balance 14,386 F1: The transactions reported in this Form 4 were effected pursuant to a pre-planned trading plan entered into in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934 and previously referenced in a MasterCard Incorporated Form 8-K filed on February 9, 2016. The pre-planned trading plan was adopted by the reporting person on February 3, 2016. Row 2 · 2016-04-15 · Sale · Disposed 5,784 · Balance 8,602 F1: The transactions reported in this Form 4 were effected pursuant to a pre-planned trading plan entered into in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934 and previously referenced in a MasterCard Incorporated Form 8-K filed on February 9, 2016. The pre-planned trading plan was adopted by the reporting person on February 3, 2016. |
| Employee Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $90.13 · Expires 2025-03-01 | Direct | 23,136 |
Reported balance
After 2016-04-15 transaction · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · 2016-04-15 · Exercise / conversion · Disposed 5,784 · Balance 23,136 F1: The transactions reported in this Form 4 were effected pursuant to a pre-planned trading plan entered into in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934 and previously referenced in a MasterCard Incorporated Form 8-K filed on February 9, 2016. The pre-planned trading plan was adopted by the reporting person on February 3, 2016. F2: The reporting person was awarded 28,920 employee stock options on March 1, 2015, of which 7,230 have vested. The remaining 21,690 employee stock options will vest in three annual installments beginning on March 1, 2017. |
Filing footnotes · ownership attribution and instrument terms
F1: The transactions reported in this Form 4 were effected pursuant to a pre-planned trading plan entered into in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934 and previously referenced in a MasterCard Incorporated Form 8-K filed on February 9, 2016. The pre-planned trading plan was adopted by the reporting person on February 3, 2016.
F2: The reporting person was awarded 28,920 employee stock options on March 1, 2015, of which 7,230 have vested. The remaining 21,690 employee stock options will vest in three annual installments beginning on March 1, 2017.
Past disclosures · reporting ended (1)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
PPD, Inc.
Report date December 08, 2021 · Filed December 08, 2021
Section 16 reporting ended · disclosed 2021-12-08. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 0 |
Ending reported balance
After 2021-12-08 transaction · row 2
2 source rows · reconciled sequenceRow 1 · 2021-12-08 · Grant · Acquired 21,492 · Balance 21,492 F1: On December 8, 2021, Thermo Fisher Scientific Inc., a Delaware corporation ("Buyer"), acquired the Issuer pursuant to a certain Agreement and Plan of Merger entered into by and among the Issuer, Buyer and Powder Acquisition Corp., a Delaware corporation and wholly-owned subsidiary of Buyer ("Merger Sub"), dated as of April 15, 2021 (the "Merger Agreement"). In accordance with the Merger Agreement, the Issuer merged with and into Merger Sub, with the Issuer surviving such merger as a wholly-owned subsidiary of Buyer (the "Merger"). At the effective time of the Merger, each issued and outstanding share of the Issuer's common stock (other than certain excluded shares) automatically converted into the right to receive $47.50 in cash (the "Merger Consideration"). F2: Prior to the Merger, the Reporting Person held certain restricted stock units subject to performance-based vesting criteria ("PSUs") which were not included on prior reports as the performance-based vesting criteria had not been satisfied. At the effective time of the Merger, each unvested PSU was canceled and converted into a restricted stock unit with substantially the same terms as were applicable to such PSU immediately prior to the effective time of the Merger (other than performance-based vesting conditions) with respect to a number of shares of Buyer equal to the product of (a) the Merger Consideration divided by the price of Buyer stock prior to the Merger, as determined in accordance with the Merger Agreement (the "Exchange Ratio") and (b) the number of shares of Issuer common stock subject to such PSU, based on the actual level of performance deemed achieved prior to the Merger. Row 2 · 2021-12-08 · Disposition to issuer · Disposed 21,492 · Balance 0 F1: On December 8, 2021, Thermo Fisher Scientific Inc., a Delaware corporation ("Buyer"), acquired the Issuer pursuant to a certain Agreement and Plan of Merger entered into by and among the Issuer, Buyer and Powder Acquisition Corp., a Delaware corporation and wholly-owned subsidiary of Buyer ("Merger Sub"), dated as of April 15, 2021 (the "Merger Agreement"). In accordance with the Merger Agreement, the Issuer merged with and into Merger Sub, with the Issuer surviving such merger as a wholly-owned subsidiary of Buyer (the "Merger"). At the effective time of the Merger, each issued and outstanding share of the Issuer's common stock (other than certain excluded shares) automatically converted into the right to receive $47.50 in cash (the "Merger Consideration"). F2: Prior to the Merger, the Reporting Person held certain restricted stock units subject to performance-based vesting criteria ("PSUs") which were not included on prior reports as the performance-based vesting criteria had not been satisfied. At the effective time of the Merger, each unvested PSU was canceled and converted into a restricted stock unit with substantially the same terms as were applicable to such PSU immediately prior to the effective time of the Merger (other than performance-based vesting conditions) with respect to a number of shares of Buyer equal to the product of (a) the Merger Consideration divided by the price of Buyer stock prior to the Merger, as determined in accordance with the Merger Agreement (the "Exchange Ratio") and (b) the number of shares of Issuer common stock subject to such PSU, based on the actual level of performance deemed achieved prior to the Merger. F6: Following the closing of the Merger, the Reporting Person's employment was terminated and the vesting of unvested equity awards of Buyer will be accelerated pursuant to the terms of the Merger Agreement. |
| Stock Options (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $19.02 · Expires 2028-09-27 | Direct | 0 |
Reported balance
After 2021-12-08 transaction · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · 2021-12-08 · Disposition to issuer · Disposed 47,339 · Balance 0 F1: On December 8, 2021, Thermo Fisher Scientific Inc., a Delaware corporation ("Buyer"), acquired the Issuer pursuant to a certain Agreement and Plan of Merger entered into by and among the Issuer, Buyer and Powder Acquisition Corp., a Delaware corporation and wholly-owned subsidiary of Buyer ("Merger Sub"), dated as of April 15, 2021 (the "Merger Agreement"). In accordance with the Merger Agreement, the Issuer merged with and into Merger Sub, with the Issuer surviving such merger as a wholly-owned subsidiary of Buyer (the "Merger"). At the effective time of the Merger, each issued and outstanding share of the Issuer's common stock (other than certain excluded shares) automatically converted into the right to receive $47.50 in cash (the "Merger Consideration"). F3: These options, of which 31,559 were unvested and scheduled to vest in equal installments on July 23, 2022 and 2023, were canceled in the Merger in exchange for a cash payment per underlying share equal to the difference between the exercise price of the option and the Merger Consideration. |
| Stock Options (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $14.55 · Expires 2028-09-27 | Direct | 31,560 |
Reported balance
After 2021-12-08 transaction · row 4
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 4 · 2021-12-08 · Grant · Acquired 31,560 · Balance 31,560 F4: These options, of which 31,560 options were eligible to vest in equal installments upon the achievement of certain EBITDA-based vesting conditions for the fiscal year 2021 and 2022 and were not included on prior reports as the performance-based vesting criteria had not been satisfied, were canceled in the Merger in exchange for a cash payment per underlying share equal to the difference between the exercise price of the option and the Merger Consideration. |
| Stock Options (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $14.55 · Expires 2028-09-27 | Direct | 0 |
Reported balance
After 2021-12-08 transaction · row 5
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 5 · 2021-12-08 · Disposition to issuer · Disposed 31,560 · Balance 0 F1: On December 8, 2021, Thermo Fisher Scientific Inc., a Delaware corporation ("Buyer"), acquired the Issuer pursuant to a certain Agreement and Plan of Merger entered into by and among the Issuer, Buyer and Powder Acquisition Corp., a Delaware corporation and wholly-owned subsidiary of Buyer ("Merger Sub"), dated as of April 15, 2021 (the "Merger Agreement"). In accordance with the Merger Agreement, the Issuer merged with and into Merger Sub, with the Issuer surviving such merger as a wholly-owned subsidiary of Buyer (the "Merger"). At the effective time of the Merger, each issued and outstanding share of the Issuer's common stock (other than certain excluded shares) automatically converted into the right to receive $47.50 in cash (the "Merger Consideration"). F4: These options, of which 31,560 options were eligible to vest in equal installments upon the achievement of certain EBITDA-based vesting conditions for the fiscal year 2021 and 2022 and were not included on prior reports as the performance-based vesting criteria had not been satisfied, were canceled in the Merger in exchange for a cash payment per underlying share equal to the difference between the exercise price of the option and the Merger Consideration. |
| Stock Options (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $37.22 · Expires 2031-02-11 | Direct | 0 |
Reported balance
After 2021-12-08 transaction · row 6
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 6 · 2021-12-08 · Disposition to issuer · Disposed 24,524 · Balance 0 F1: On December 8, 2021, Thermo Fisher Scientific Inc., a Delaware corporation ("Buyer"), acquired the Issuer pursuant to a certain Agreement and Plan of Merger entered into by and among the Issuer, Buyer and Powder Acquisition Corp., a Delaware corporation and wholly-owned subsidiary of Buyer ("Merger Sub"), dated as of April 15, 2021 (the "Merger Agreement"). In accordance with the Merger Agreement, the Issuer merged with and into Merger Sub, with the Issuer surviving such merger as a wholly-owned subsidiary of Buyer (the "Merger"). At the effective time of the Merger, each issued and outstanding share of the Issuer's common stock (other than certain excluded shares) automatically converted into the right to receive $47.50 in cash (the "Merger Consideration"). F5: This option, which provided for vesting in four equal installments beginning on February 11, 2022, was canceled and converted into an option to purchase a number of shares of Buyer common stock equal to the number of shares of Issuer common stock subject to such option multiplied by the Exchange Ratio, at a price per share equal to the exercise price per share divided by the Exchange Ratio, plus a cash payment in respect of any fractional shares as provided in the Merger Agreement. F6: Following the closing of the Merger, the Reporting Person's employment was terminated and the vesting of unvested equity awards of Buyer will be accelerated pursuant to the terms of the Merger Agreement. |
Filing footnotes · ownership attribution and instrument terms
F1: On December 8, 2021, Thermo Fisher Scientific Inc., a Delaware corporation ("Buyer"), acquired the Issuer pursuant to a certain Agreement and Plan of Merger entered into by and among the Issuer, Buyer and Powder Acquisition Corp., a Delaware corporation and wholly-owned subsidiary of Buyer ("Merger Sub"), dated as of April 15, 2021 (the "Merger Agreement"). In accordance with the Merger Agreement, the Issuer merged with and into Merger Sub, with the Issuer surviving such merger as a wholly-owned subsidiary of Buyer (the "Merger"). At the effective time of the Merger, each issued and outstanding share of the Issuer's common stock (other than certain excluded shares) automatically converted into the right to receive $47.50 in cash (the "Merger Consideration").
F2: Prior to the Merger, the Reporting Person held certain restricted stock units subject to performance-based vesting criteria ("PSUs") which were not included on prior reports as the performance-based vesting criteria had not been satisfied. At the effective time of the Merger, each unvested PSU was canceled and converted into a restricted stock unit with substantially the same terms as were applicable to such PSU immediately prior to the effective time of the Merger (other than performance-based vesting conditions) with respect to a number of shares of Buyer equal to the product of (a) the Merger Consideration divided by the price of Buyer stock prior to the Merger, as determined in accordance with the Merger Agreement (the "Exchange Ratio") and (b) the number of shares of Issuer common stock subject to such PSU, based on the actual level of performance deemed achieved prior to the Merger.
F3: These options, of which 31,559 were unvested and scheduled to vest in equal installments on July 23, 2022 and 2023, were canceled in the Merger in exchange for a cash payment per underlying share equal to the difference between the exercise price of the option and the Merger Consideration.
F4: These options, of which 31,560 options were eligible to vest in equal installments upon the achievement of certain EBITDA-based vesting conditions for the fiscal year 2021 and 2022 and were not included on prior reports as the performance-based vesting criteria had not been satisfied, were canceled in the Merger in exchange for a cash payment per underlying share equal to the difference between the exercise price of the option and the Merger Consideration.
F5: This option, which provided for vesting in four equal installments beginning on February 11, 2022, was canceled and converted into an option to purchase a number of shares of Buyer common stock equal to the number of shares of Issuer common stock subject to such option multiplied by the Exchange Ratio, at a price per share equal to the exercise price per share divided by the Exchange Ratio, plus a cash payment in respect of any fractional shares as provided in the Merger Agreement.
F6: Following the closing of the Merger, the Reporting Person's employment was terminated and the vesting of unvested equity awards of Buyer will be accelerated pursuant to the terms of the Merger Agreement.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| December 08, 2021 Filed Dec 8, 2021 16:38 UTC | PPD, Inc. PPD · Entity 15247 | Disposition to issuerStock Options (Right to Buy) · Derivative | 24,524 | Not disclosed Strike: $37.22 | Not disclosed |
DisclosureSEC source: 0001437749-21-028108 · rdgdoc.xml · derivative · entry 6 Garrow Ronald E · CIK 0001573297 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 24,524 shares Expires 2031-02-11 F1 · kind: On December 8, 2021, Thermo Fisher Scientific Inc., a Delaware corporation ("Buyer"), acquired the Issuer pursuant to a certain Agreement and Plan of Merger entered into by and among the Issuer, Buyer and Powder Acquisition Corp., a Delaware corporation and wholly-owned subsidiary of Buyer ("Merger Sub"), dated as of April 15, 2021 (the "Merger Agreement"). In accordance with the Merger Agreement, the Issuer merged with and into Merger Sub, with the Issuer surviving such merger as a wholly-owned subsidiary of Buyer (the "Merger"). At the effective time of the Merger, each issued and outstanding share of the Issuer's common stock (other than certain excluded shares) automatically converted into the right to receive $47.50 in cash (the "Merger Consideration"). F5 · price: This option, which provided for vesting in four equal installments beginning on February 11, 2022, was canceled and converted into an option to purchase a number of shares of Buyer common stock equal to the number of shares of Issuer common stock subject to such option multiplied by the Exchange Ratio, at a price per share equal to the exercise price per share divided by the Exchange Ratio, plus a cash payment in respect of any fractional shares as provided in the Merger Agreement. F6 · price: Following the closing of the Merger, the Reporting Person's employment was terminated and the vesting of unvested equity awards of Buyer will be accelerated pursuant to the terms of the Merger Agreement. F6 · derivative.exercise_date: Following the closing of the Merger, the Reporting Person's employment was terminated and the vesting of unvested equity awards of Buyer will be accelerated pursuant to the terms of the Merger Agreement. Read SEC document |
| December 08, 2021 Filed Dec 8, 2021 16:38 UTC | PPD, Inc. PPD · Entity 15247 | Disposition to issuerStock Options (Right to Buy) · Derivative | 31,560 | $32.95 Strike: $14.55 | $1,039,902.00 |
DisclosureSEC source: 0001437749-21-028108 · rdgdoc.xml · derivative · entry 5 Garrow Ronald E · CIK 0001573297 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 31,560 shares Expires 2028-09-27 F1 · kind: On December 8, 2021, Thermo Fisher Scientific Inc., a Delaware corporation ("Buyer"), acquired the Issuer pursuant to a certain Agreement and Plan of Merger entered into by and among the Issuer, Buyer and Powder Acquisition Corp., a Delaware corporation and wholly-owned subsidiary of Buyer ("Merger Sub"), dated as of April 15, 2021 (the "Merger Agreement"). In accordance with the Merger Agreement, the Issuer merged with and into Merger Sub, with the Issuer surviving such merger as a wholly-owned subsidiary of Buyer (the "Merger"). At the effective time of the Merger, each issued and outstanding share of the Issuer's common stock (other than certain excluded shares) automatically converted into the right to receive $47.50 in cash (the "Merger Consideration"). F4 · price: These options, of which 31,560 options were eligible to vest in equal installments upon the achievement of certain EBITDA-based vesting conditions for the fiscal year 2021 and 2022 and were not included on prior reports as the performance-based vesting criteria had not been satisfied, were canceled in the Merger in exchange for a cash payment per underlying share equal to the difference between the exercise price of the option and the Merger Consideration. F4 · derivative.exercise_date: These options, of which 31,560 options were eligible to vest in equal installments upon the achievement of certain EBITDA-based vesting conditions for the fiscal year 2021 and 2022 and were not included on prior reports as the performance-based vesting criteria had not been satisfied, were canceled in the Merger in exchange for a cash payment per underlying share equal to the difference between the exercise price of the option and the Merger Consideration. Read SEC document |
| December 08, 2021 Filed Dec 8, 2021 16:38 UTC | PPD, Inc. PPD · Entity 15247 | GrantStock Options (Right to Buy) · Derivative | 31,560 | $0.00 Strike: $14.55 | $0.00 |
DisclosureSEC source: 0001437749-21-028108 · rdgdoc.xml · derivative · entry 4 Garrow Ronald E · CIK 0001573297 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 31,560 Underlying: Common Stock · 31,560 shares Expires 2028-09-27 F4 · kind: These options, of which 31,560 options were eligible to vest in equal installments upon the achievement of certain EBITDA-based vesting conditions for the fiscal year 2021 and 2022 and were not included on prior reports as the performance-based vesting criteria had not been satisfied, were canceled in the Merger in exchange for a cash payment per underlying share equal to the difference between the exercise price of the option and the Merger Consideration. F4 · derivative.exercise_date: These options, of which 31,560 options were eligible to vest in equal installments upon the achievement of certain EBITDA-based vesting conditions for the fiscal year 2021 and 2022 and were not included on prior reports as the performance-based vesting criteria had not been satisfied, were canceled in the Merger in exchange for a cash payment per underlying share equal to the difference between the exercise price of the option and the Merger Consideration. Read SEC document |
| December 08, 2021 Filed Dec 8, 2021 16:38 UTC | PPD, Inc. PPD · Entity 15247 | Disposition to issuerStock Options (Right to Buy) · Derivative | 47,339 | $28.48 Strike: $19.02 | $1,348,214.72 |
DisclosureSEC source: 0001437749-21-028108 · rdgdoc.xml · derivative · entry 3 Garrow Ronald E · CIK 0001573297 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 47,339 shares Expires 2028-09-27 F1 · kind: On December 8, 2021, Thermo Fisher Scientific Inc., a Delaware corporation ("Buyer"), acquired the Issuer pursuant to a certain Agreement and Plan of Merger entered into by and among the Issuer, Buyer and Powder Acquisition Corp., a Delaware corporation and wholly-owned subsidiary of Buyer ("Merger Sub"), dated as of April 15, 2021 (the "Merger Agreement"). In accordance with the Merger Agreement, the Issuer merged with and into Merger Sub, with the Issuer surviving such merger as a wholly-owned subsidiary of Buyer (the "Merger"). At the effective time of the Merger, each issued and outstanding share of the Issuer's common stock (other than certain excluded shares) automatically converted into the right to receive $47.50 in cash (the "Merger Consideration"). F3 · price: These options, of which 31,559 were unvested and scheduled to vest in equal installments on July 23, 2022 and 2023, were canceled in the Merger in exchange for a cash payment per underlying share equal to the difference between the exercise price of the option and the Merger Consideration. F3 · derivative.exercise_date: These options, of which 31,559 were unvested and scheduled to vest in equal installments on July 23, 2022 and 2023, were canceled in the Merger in exchange for a cash payment per underlying share equal to the difference between the exercise price of the option and the Merger Consideration. Read SEC document |
| December 08, 2021 Filed Dec 8, 2021 16:38 UTC | PPD, Inc. PPD · Entity 15247 | Disposition to issuerCommon Stock | 21,492 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001437749-21-028108 · rdgdoc.xml · nonDerivative · entry 2 Garrow Ronald E · CIK 0001573297 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · kind: On December 8, 2021, Thermo Fisher Scientific Inc., a Delaware corporation ("Buyer"), acquired the Issuer pursuant to a certain Agreement and Plan of Merger entered into by and among the Issuer, Buyer and Powder Acquisition Corp., a Delaware corporation and wholly-owned subsidiary of Buyer ("Merger Sub"), dated as of April 15, 2021 (the "Merger Agreement"). In accordance with the Merger Agreement, the Issuer merged with and into Merger Sub, with the Issuer surviving such merger as a wholly-owned subsidiary of Buyer (the "Merger"). At the effective time of the Merger, each issued and outstanding share of the Issuer's common stock (other than certain excluded shares) automatically converted into the right to receive $47.50 in cash (the "Merger Consideration"). F2 · price: Prior to the Merger, the Reporting Person held certain restricted stock units subject to performance-based vesting criteria ("PSUs") which were not included on prior reports as the performance-based vesting criteria had not been satisfied. At the effective time of the Merger, each unvested PSU was canceled and converted into a restricted stock unit with substantially the same terms as were applicable to such PSU immediately prior to the effective time of the Merger (other than performance-based vesting conditions) with respect to a number of shares of Buyer equal to the product of (a) the Merger Consideration divided by the price of Buyer stock prior to the Merger, as determined in accordance with the Merger Agreement (the "Exchange Ratio") and (b) the number of shares of Issuer common stock subject to such PSU, based on the actual level of performance deemed achieved prior to the Merger. F6 · price: Following the closing of the Merger, the Reporting Person's employment was terminated and the vesting of unvested equity awards of Buyer will be accelerated pursuant to the terms of the Merger Agreement. Read SEC document |
| December 08, 2021 Filed Dec 8, 2021 16:38 UTC | PPD, Inc. PPD · Entity 15247 | GrantCommon Stock | 21,492 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-21-028108 · rdgdoc.xml · nonDerivative · entry 1 Garrow Ronald E · CIK 0001573297 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,492 F1 · kind: On December 8, 2021, Thermo Fisher Scientific Inc., a Delaware corporation ("Buyer"), acquired the Issuer pursuant to a certain Agreement and Plan of Merger entered into by and among the Issuer, Buyer and Powder Acquisition Corp., a Delaware corporation and wholly-owned subsidiary of Buyer ("Merger Sub"), dated as of April 15, 2021 (the "Merger Agreement"). In accordance with the Merger Agreement, the Issuer merged with and into Merger Sub, with the Issuer surviving such merger as a wholly-owned subsidiary of Buyer (the "Merger"). At the effective time of the Merger, each issued and outstanding share of the Issuer's common stock (other than certain excluded shares) automatically converted into the right to receive $47.50 in cash (the "Merger Consideration"). F2 · kind: Prior to the Merger, the Reporting Person held certain restricted stock units subject to performance-based vesting criteria ("PSUs") which were not included on prior reports as the performance-based vesting criteria had not been satisfied. At the effective time of the Merger, each unvested PSU was canceled and converted into a restricted stock unit with substantially the same terms as were applicable to such PSU immediately prior to the effective time of the Merger (other than performance-based vesting conditions) with respect to a number of shares of Buyer equal to the product of (a) the Merger Consideration divided by the price of Buyer stock prior to the Merger, as determined in accordance with the Merger Agreement (the "Exchange Ratio") and (b) the number of shares of Issuer common stock subject to such PSU, based on the actual level of performance deemed achieved prior to the Merger. F2 · shares: Prior to the Merger, the Reporting Person held certain restricted stock units subject to performance-based vesting criteria ("PSUs") which were not included on prior reports as the performance-based vesting criteria had not been satisfied. At the effective time of the Merger, each unvested PSU was canceled and converted into a restricted stock unit with substantially the same terms as were applicable to such PSU immediately prior to the effective time of the Merger (other than performance-based vesting conditions) with respect to a number of shares of Buyer equal to the product of (a) the Merger Consideration divided by the price of Buyer stock prior to the Merger, as determined in accordance with the Merger Agreement (the "Exchange Ratio") and (b) the number of shares of Issuer common stock subject to such PSU, based on the actual level of performance deemed achieved prior to the Merger. Read SEC document |
| March 02, 2021 Filed Mar 4, 2021 17:01 UTC | PPD, Inc. PPD · Entity 15247 | Exercise / conversionCommon Stock · Derivative | 46,551 | $0.00 Strike: $19.02 | $0.00 |
DisclosureSEC source: 0001628280-21-003936 · wf-form4_161489529743332.xml · derivative · entry 5 Garrow Ronald E · CIK 0001573297 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 47,339 Underlying: Common Stock · 46,551 shares Expires 2028-09-27 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: The remaining 47,339 stock options are unvested and will vest in equal installments on July 23, 2021, July 23, 2022, and July 23, 2023. Read SEC document |
| March 02, 2021 Filed Mar 4, 2021 17:01 UTC | PPD, Inc. PPD · Entity 15247 | Exercise / conversionCommon Stock · Derivative | 22,850 | $0.00 Strike: $14.55 | $0.00 |
DisclosureSEC source: 0001628280-21-003936 · wf-form4_161489529743332.xml · derivative · entry 4 Garrow Ronald E · CIK 0001573297 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 22,850 shares Expires 2028-09-27 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The option vests in five equal annual installments based on the Issuer's satisfaction of certain EBITDA-based vesting conditions for each of the fiscal years ending December 31, 2018, 2019, 2020, 2021, and 2022. Options listed in the table do not include the 31,560 stock options eligible to vest based on the Issuer's satisfaction of certain EBITDA-based vesting conditions for each of the fiscal years ending December 31, 2021 and 2022. Read SEC document |
| March 02, 2021 Filed Mar 4, 2021 17:01 UTC | PPD, Inc. PPD · Entity 15247 | SaleCommon Stock | 69,401 | $36.38 | $2,524,808.38 |
DisclosureSEC source: 0001628280-21-003936 · wf-form4_161489529743332.xml · nonDerivative · entry 3 Garrow Ronald E · CIK 0001573297 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · kind: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $36.31 to $36.48, inclusive. The reporting person undertakes to provide toPPD, Inc. (the "Issuer"), any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| March 02, 2021 Filed Mar 4, 2021 17:01 UTC | PPD, Inc. PPD · Entity 15247 | Exercise / conversionCommon Stock | 46,551 | $19.02 | $885,400.02 |
DisclosureSEC source: 0001628280-21-003936 · wf-form4_161489529743332.xml · nonDerivative · entry 2 Garrow Ronald E · CIK 0001573297 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 69,401 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 02, 2021 Filed Mar 4, 2021 17:01 UTC | PPD, Inc. PPD · Entity 15247 | Exercise / conversionCommon Stock | 22,850 | $14.55 | $332,467.50 |
DisclosureSEC source: 0001628280-21-003936 · wf-form4_161489529743332.xml · nonDerivative · entry 1 Garrow Ronald E · CIK 0001573297 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,850 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 11, 2021 Filed Feb 16, 2021 17:00 UTC | PPD, Inc. PPD · Entity 15247 | GrantStock Options (Right to Buy) · Derivative | 24,524 | $0.00 Strike: $37.22 | $0.00 |
DisclosureSEC source: 0000899243-21-006671 · doc4.xml · derivative · entry 2 Garrow Ronald E · CIK 0001573297 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,524 Underlying: Common Stock · 24,524 shares Expires 2031-02-11 F3 · derivative.exercise_date: These options to purchase common stock vest in four equal annual installments beginning on the first anniversary of the grant date. Read SEC document |
| February 11, 2021 Filed Feb 16, 2021 17:00 UTC | PPD, Inc. PPD · Entity 15247 | GrantStock Options (Right to Buy) · Derivative | 17,359 | $0.00 Strike: $14.55 | $0.00 |
DisclosureSEC source: 0000899243-21-006671 · doc4.xml · derivative · entry 1 Garrow Ronald E · CIK 0001573297 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,850 Underlying: Common Stock · 17,359 shares Expires 2028-09-27 F1 · kind: Represents previously awarded stock options vesting upon the achievement of certain EBITDA vesting conditions for fiscal 2020, which were determined to be earned subject to the receipt by the Issuer of the completed audit of its fiscal 2020 financial statements. F2 · derivative.exercise_date: Represents 22,850 vested stock options. Does not include an additional 31,560 stock options with an exercise price of $14.55 which are eligible to vest upon the achievement of certain EBITDA-based vesting conditions for fiscal years 2021-2022. Read SEC document |
| September 18, 2020 Filed Sep 22, 2020 17:01 UTC | PPD, Inc. PPD · Entity 15247 | Exercise / conversionStock Options (Right to Buy) · Derivative | 9,500 | $0.00 Strike: $14.55 | $0.00 |
DisclosureSEC source: 0000899243-20-025924 · doc4.xml · derivative · entry 3 Garrow Ronald E · CIK 0001573297 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,491 Underlying: Common Stock · 9,500 shares Expires 2028-09-27 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: Represents vested stock options. Does not include an additional 48,919 stock options with an exercise price of $14.55 which are eligible to vest upon the achievement of certain EBITDA-based vesting conditions for fiscal years 2020-2022. Read SEC document |
| September 18, 2020 Filed Sep 22, 2020 17:01 UTC | PPD, Inc. PPD · Entity 15247 | SaleCommon Stock | 9,500 | $34.12 | $324,140.00 |
DisclosureSEC source: 0000899243-20-025924 · doc4.xml · nonDerivative · entry 2 Garrow Ronald E · CIK 0001573297 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $34.12 to $34.13, inclusive. The reporting person undertakes to provide to PPD, Inc. (the "Issuer"), any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| September 18, 2020 Filed Sep 22, 2020 17:01 UTC | PPD, Inc. PPD · Entity 15247 | Exercise / conversionCommon Stock | 9,500 | $14.55 | $138,225.00 |
DisclosureSEC source: 0000899243-20-025924 · doc4.xml · nonDerivative · entry 1 Garrow Ronald E · CIK 0001573297 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,500 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 19, 2020 Filed Feb 21, 2020 19:12 UTC | PPD, Inc. PPD · Entity 15247 | GrantStock Options (Right to Buy) · Derivative | 14,991 | $0.00 Strike: $14.55 | $0.00 |
DisclosureSEC source: 0000899243-20-005536 · doc4.xml · derivative · entry 1 Garrow Ronald E · CIK 0001573297 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,991 Underlying: Common Stock · 14,991 shares Expires 2028-09-27 F1 · kind: Represents previously awarded stock options earned upon the achievement of certain EBITDA vesting conditions for fiscal 2019. F2 · derivative.exercise_date: Represents 14,991 vested stock options. Does not include an additional 48,919 stock options with an exercise price of $14.55 which are eligible to vest upon the achievement of certain EBITDA-based vesting conditions for fiscal years 2020-2022. Read SEC document |
| April 15, 2016 Filed Apr 19, 2016 20:45 UTC | Mastercard Inc MA · Entity 1763 | Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 5,784 | $0.00 Strike: $90.13 | $0.00 |
DisclosureSEC source: 0001141391-16-000126 · wf-form4_146109873041495.xml · derivative · entry 3 Garrow Ronald E · CIK 0001573297 · Chief Human Resources Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,136 Underlying: Class A Common Stock · 5,784 shares Expires 2025-03-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: The transactions reported in this Form 4 were effected pursuant to a pre-planned trading plan entered into in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934 and previously referenced in a MasterCard Incorporated Form 8-K filed on February 9, 2016. The pre-planned trading plan was adopted by the reporting person on February 3, 2016. F2 · derivative.exercise_date: The reporting person was awarded 28,920 employee stock options on March 1, 2015, of which 7,230 have vested. The remaining 21,690 employee stock options will vest in three annual installments beginning on March 1, 2017. Read SEC document |
| April 15, 2016 Filed Apr 19, 2016 20:45 UTC | Mastercard Inc MA · Entity 1763 | SaleClass A Common Stock | 5,784 | $97.00 | $561,048.00 |
DisclosureSEC source: 0001141391-16-000126 · wf-form4_146109873041495.xml · nonDerivative · entry 2 Garrow Ronald E · CIK 0001573297 · Chief Human Resources Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,602 F1 · shares: The transactions reported in this Form 4 were effected pursuant to a pre-planned trading plan entered into in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934 and previously referenced in a MasterCard Incorporated Form 8-K filed on February 9, 2016. The pre-planned trading plan was adopted by the reporting person on February 3, 2016. Read SEC document |
| April 15, 2016 Filed Apr 19, 2016 20:45 UTC | Mastercard Inc MA · Entity 1763 | Exercise / conversionClass A Common Stock | 5,784 | $90.13 | $521,311.92 |
DisclosureSEC source: 0001141391-16-000126 · wf-form4_146109873041495.xml · nonDerivative · entry 1 Garrow Ronald E · CIK 0001573297 · Chief Human Resources Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,386 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: The transactions reported in this Form 4 were effected pursuant to a pre-planned trading plan entered into in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934 and previously referenced in a MasterCard Incorporated Form 8-K filed on February 9, 2016. The pre-planned trading plan was adopted by the reporting person on February 3, 2016. Read SEC document |
| April 04, 2016 Filed Apr 6, 2016 16:11 UTC | Mastercard Inc MA · Entity 1763 | Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 4,374 | $0.00 Strike: $77.72 | $0.00 |
DisclosureSEC source: 0001141391-16-000118 · wf-form4_145995908320074.xml · derivative · entry 7 Garrow Ronald E · CIK 0001573297 · Chief Human Resources Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,746 Underlying: Class A Common Stock · 4,374 shares Expires 2024-03-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: The reporting person was awarded 17,496 employee stock options on March 1, 2014, of which 8,746 previously vested. The remaining 8,746 employee stock options will vest in two equal annual installments beginning on March 1, 2017. Read SEC document |
| April 04, 2016 Filed Apr 6, 2016 16:11 UTC | Mastercard Inc MA · Entity 1763 | Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 3,550 | $0.00 Strike: $51.83 | $0.00 |
DisclosureSEC source: 0001141391-16-000118 · wf-form4_145995908320074.xml · derivative · entry 6 Garrow Ronald E · CIK 0001573297 · Chief Human Resources Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,550 Underlying: Class A Common Stock · 3,550 shares Expires 2023-03-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: The reporting person was awarded 14,200 employee stock options on March 1, 2013, of which 10,650 previously vested. The remaining 3,550 employee stock options will vest on March 1, 2017. Read SEC document |
| April 04, 2016 Filed Apr 6, 2016 16:11 UTC | Mastercard Inc MA · Entity 1763 | Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 2,110 | $0.00 Strike: $42.04 | $0.00 |
DisclosureSEC source: 0001141391-16-000118 · wf-form4_145995908320074.xml · derivative · entry 5 Garrow Ronald E · CIK 0001573297 · Chief Human Resources Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Class A Common Stock · 2,110 shares Expires 2022-03-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: The reporting person was awarded 8,440 employee stock options on March 1, 2012, which vested in four equal installments beginning on March 1, 2013. Read SEC document |
| April 04, 2016 Filed Apr 6, 2016 16:11 UTC | Mastercard Inc MA · Entity 1763 | SaleClass A Common Stock | 10,034 | $95.75 | $960,755.50 |
DisclosureSEC source: 0001141391-16-000118 · wf-form4_145995908320074.xml · nonDerivative · entry 4 Garrow Ronald E · CIK 0001573297 · Chief Human Resources Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,602 F1 · shares: The transactions reported in this Form 4 were effected pursuant to a pre-planned trading plan entered into in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934 and previously referenced in a MasterCard Incorporated Form 8-K filed on February 9, 2016. The pre-planned trading plan was adopted by the reporting person on February 3, 2016. F2 · price: Represents the weighted average sales price for price increments ranging from $95.6000 to $96.1000. Read SEC document |
| April 04, 2016 Filed Apr 6, 2016 16:11 UTC | Mastercard Inc MA · Entity 1763 | Exercise / conversionClass A Common Stock | 4,374 | $77.72 | $339,947.28 |
DisclosureSEC source: 0001141391-16-000118 · wf-form4_145995908320074.xml · nonDerivative · entry 3 Garrow Ronald E · CIK 0001573297 · Chief Human Resources Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,636 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| April 04, 2016 Filed Apr 6, 2016 16:11 UTC | Mastercard Inc MA · Entity 1763 | Exercise / conversionClass A Common Stock | 3,550 | $51.83 | $183,996.50 |
DisclosureSEC source: 0001141391-16-000118 · wf-form4_145995908320074.xml · nonDerivative · entry 2 Garrow Ronald E · CIK 0001573297 · Chief Human Resources Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,262 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| April 04, 2016 Filed Apr 6, 2016 16:11 UTC | Mastercard Inc MA · Entity 1763 | Exercise / conversionClass A Common Stock | 2,110 | $42.04 | $88,704.40 |
DisclosureSEC source: 0001141391-16-000118 · wf-form4_145995908320074.xml · nonDerivative · entry 1 Garrow Ronald E · CIK 0001573297 · Chief Human Resources Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,712 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| April 04, 2016 Filed Apr 8, 2016 21:05 UTC Amendment | Mastercard Inc MA · Entity 1763 | Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 4,374 | $0.00 Strike: $77.72 | $0.00 |
DisclosureSEC source: 0001141391-16-000121 · wf-form4a_146014952121500.xml · derivative · entry 3 Garrow Ronald E · CIK 0001573297 · Chief Human Resources Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,748 Underlying: Class A Common Stock · 4,374 shares Expires 2024-03-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: This amended Form 4 is being filed to properly report the disposition of these stock options in connection with their exercises. F2 · shares: The transactions reported in this Form 4 were effected pursuant to a pre-planned trading plan entered into in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934 and previously referenced in a MasterCard Incorporated Form 8-K filed on February 9, 2016. The pre-planned trading plan was adopted by the reporting person on February 3, 2016. F5 · derivative.exercise_date: The reporting person was awarded 17,496 employee stock options on March 1, 2014, of which 8,748 previously vested. The remaining 8,748 employee stock options will vest in two equal annual installments beginning on March 1, 2017. Read SEC document |
| April 04, 2016 Filed Apr 8, 2016 21:05 UTC Amendment | Mastercard Inc MA · Entity 1763 | Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 3,550 | $0.00 Strike: $51.83 | $0.00 |
DisclosureSEC source: 0001141391-16-000121 · wf-form4a_146014952121500.xml · derivative · entry 2 Garrow Ronald E · CIK 0001573297 · Chief Human Resources Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,550 Underlying: Class A Common Stock · 3,550 shares Expires 2023-03-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: This amended Form 4 is being filed to properly report the disposition of these stock options in connection with their exercises. F2 · shares: The transactions reported in this Form 4 were effected pursuant to a pre-planned trading plan entered into in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934 and previously referenced in a MasterCard Incorporated Form 8-K filed on February 9, 2016. The pre-planned trading plan was adopted by the reporting person on February 3, 2016. F4 · derivative.exercise_date: The reporting person was awarded 14,200 employee stock options on March 1, 2013, of which 10,650 previously vested. The remaining 3,550 employee stock options will vest on March 1, 2017. Read SEC document |
| April 04, 2016 Filed Apr 8, 2016 21:05 UTC Amendment | Mastercard Inc MA · Entity 1763 | Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 2,110 | $0.00 Strike: $42.04 | $0.00 |
DisclosureSEC source: 0001141391-16-000121 · wf-form4a_146014952121500.xml · derivative · entry 1 Garrow Ronald E · CIK 0001573297 · Chief Human Resources Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Class A Common Stock · 2,110 shares Expires 2022-03-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: This amended Form 4 is being filed to properly report the disposition of these stock options in connection with their exercises. F2 · shares: The transactions reported in this Form 4 were effected pursuant to a pre-planned trading plan entered into in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934 and previously referenced in a MasterCard Incorporated Form 8-K filed on February 9, 2016. The pre-planned trading plan was adopted by the reporting person on February 3, 2016. F3 · derivative.exercise_date: The reporting person was awarded 8,440 employee stock options on March 1, 2012, which vested in four equal installments beginning on March 1, 2013. Read SEC document |
| March 01, 2016 Filed Mar 2, 2016 23:55 UTC | Mastercard Inc MA · Entity 1763 | GrantEmployee Stock Option (right to buy) · Derivative | 26,912 | $0.00 Strike: $90.10 | $0.00 |
DisclosureSEC source: 0001141391-16-000105 · wf-form4_145696290023046.xml · derivative · entry 2 Garrow Ronald E · CIK 0001573297 · Chief Human Resources Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,912 Underlying: Class A Common Stock · 26,912 shares Expires 2026-03-01 F2 · derivative.exercise_date: The employee stock options vest in four (4) equal annual installments beginning March 1, 2017. Read SEC document |
| February 29, 2016 Filed Mar 2, 2016 23:55 UTC | Mastercard Inc MA · Entity 1763 | Tax withholdingClass A Common Stock | 1,250 | $87.88 | $109,843.75 |
DisclosureSEC source: 0001141391-16-000105 · wf-form4_145696290023046.xml · nonDerivative · entry 1 Garrow Ronald E · CIK 0001573297 · Chief Human Resources Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,602 F1 · shares: Represents withholding of shares to pay tax liability incident to the vesting of restricted stock units pursuant to the terms of a stockholder-approved stock plan. Read SEC document |
| March 02, 2015 Filed Mar 3, 2015 22:47 UTC | Mastercard Inc MA · Entity 1763 | Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 4,374 | $0.00 Strike: $77.72 | $0.00 |
DisclosureSEC source: 0001225208-15-006652 · doc4.xml · derivative · entry 9 Garrow Ronald E · CIK 0001573297 · Chief Human Resources Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,122 Underlying: Class A Common Stock · 4,374 shares Expires 2024-03-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: The Reporting Person was awarded 17,496 employee stock options on March 1, 2014, of which 4,374 have vested. The remaining 13,122 employee stock options will vest in three (3) equal annual installments beginning on March 1, 2016. Read SEC document |
| March 02, 2015 Filed Mar 3, 2015 22:47 UTC | Mastercard Inc MA · Entity 1763 | Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 3,550 | $0.00 Strike: $51.83 | $0.00 |
DisclosureSEC source: 0001225208-15-006652 · doc4.xml · derivative · entry 8 Garrow Ronald E · CIK 0001573297 · Chief Human Resources Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,100 Underlying: Class A Common Stock · 3,550 shares Expires 2023-03-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: The reporting person was awarded 14,200 employee stock options on March 1, 2013, of which 7,100 have vested. The remaining 7,100 employee stock options will vest in two (2) equal annual installments beginning on March 1, 2016. Read SEC document |
| March 02, 2015 Filed Mar 3, 2015 22:47 UTC | Mastercard Inc MA · Entity 1763 | Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 2,110 | $0.00 Strike: $42.04 | $0.00 |
DisclosureSEC source: 0001225208-15-006652 · doc4.xml · derivative · entry 7 Garrow Ronald E · CIK 0001573297 · Chief Human Resources Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,110 Underlying: Class A Common Stock · 2,110 shares Expires 2022-03-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: The reporting person was awarded 8,440 employee stock options on March 1, 2012, of which 6,330 have vested. The remaining 2,110 employee stock options will vest on March 1, 2016. Read SEC document |
| March 02, 2015 Filed Mar 3, 2015 22:47 UTC | Mastercard Inc MA · Entity 1763 | SaleClass A Common Stock | 10,034 | $90.00 | $903,060.00 |
DisclosureSEC source: 0001225208-15-006652 · doc4.xml · nonDerivative · entry 5 Garrow Ronald E · CIK 0001573297 · Chief Human Resources Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,852 Read SEC document |
| March 02, 2015 Filed Mar 3, 2015 22:47 UTC | Mastercard Inc MA · Entity 1763 | Exercise / conversionClass A Common Stock | 2,110 | $42.04 | $88,710.73 |
DisclosureSEC source: 0001225208-15-006652 · doc4.xml · nonDerivative · entry 4 Garrow Ronald E · CIK 0001573297 · Chief Human Resources Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,886 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 02, 2015 Filed Mar 3, 2015 22:47 UTC | Mastercard Inc MA · Entity 1763 | Exercise / conversionClass A Common Stock | 3,550 | $51.83 | $183,996.50 |
DisclosureSEC source: 0001225208-15-006652 · doc4.xml · nonDerivative · entry 3 Garrow Ronald E · CIK 0001573297 · Chief Human Resources Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,776 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 02, 2015 Filed Mar 3, 2015 22:47 UTC | Mastercard Inc MA · Entity 1763 | Exercise / conversionClass A Common Stock | 4,374 | $77.72 | $339,947.28 |
DisclosureSEC source: 0001225208-15-006652 · doc4.xml · nonDerivative · entry 2 Garrow Ronald E · CIK 0001573297 · Chief Human Resources Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,226 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 01, 2015 Filed Mar 3, 2015 22:47 UTC | Mastercard Inc MA · Entity 1763 | GrantEmployee Stock Option (right to buy) · Derivative | 28,920 | $0.00 Strike: $90.13 | $0.00 |
DisclosureSEC source: 0001225208-15-006652 · doc4.xml · derivative · entry 6 Garrow Ronald E · CIK 0001573297 · Chief Human Resources Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,920 Underlying: Class A Common Stock · 28,920 shares Expires 2025-03-01 F2 · derivative.exercise_date: The employee stock options vest in four (4) equal annual installments beginning March 1, 2016. Read SEC document |
| March 01, 2015 Filed Mar 3, 2015 22:47 UTC | Mastercard Inc MA · Entity 1763 | Tax withholdingClass A Common Stock | 1,102 | $90.83 | $100,089.15 |
DisclosureSEC source: 0001225208-15-006652 · doc4.xml · nonDerivative · entry 1 Garrow Ronald E · CIK 0001573297 · Chief Human Resources Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,852 F1 · shares: Represents withholding of shares to pay tax liability incident to the vesting of restricted stock units pursuant to the terms of a shareholder-approved stock plan. Read SEC document |
| October 30, 2014 Filed Nov 3, 2014 22:02 UTC | Mastercard Inc MA · Entity 1763 | Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 3,550 | $0.00 Strike: $51.83 | $0.00 |
DisclosureSEC source: 0001225208-14-022464 · doc4.xml · derivative · entry 5 Garrow Ronald E · CIK 0001573297 · Chief Human Resources Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,650 Underlying: Class A Common Stock · 3,550 shares Expires 2023-03-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: The reporting person was awarded 14,200 employee stock options on March 1, 2013, 3,550 of which have vested. The remaining 10,650 employee stock options will vest in 3 equal annual installments beginning on March 1, 2015. Read SEC document |
| October 30, 2014 Filed Nov 3, 2014 22:02 UTC | Mastercard Inc MA · Entity 1763 | Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 4,220 | $0.00 Strike: $42.04 | $0.00 |
DisclosureSEC source: 0001225208-14-022464 · doc4.xml · derivative · entry 4 Garrow Ronald E · CIK 0001573297 · Chief Human Resources Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,220 Underlying: Class A Common Stock · 4,220 shares Expires 2022-03-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: The exercise price for the reporting person's employee stock options awarded on March 1, 2012 has been changed from $42.0330 to $42.0430. This is intended to correct an administrative error in Column 4 of Table II (Derivative Securities Beneficially Owned) on the reporting person's Form 3 filed on April 2, 2013. F3 · derivative.exercise_date: The reporting person was awarded 8,440 employee stock options on March 1, 2012, 4,220 of which have vested. The remaining 4,220 employee stock options will vest in 2 equal annual installments beginning on March 1, 2015. Read SEC document |
| October 30, 2014 Filed Nov 3, 2014 22:02 UTC | Mastercard Inc MA · Entity 1763 | SaleClass A Common Stock | 7,770 | $80.00 | $621,600.00 |
DisclosureSEC source: 0001225208-14-022464 · doc4.xml · nonDerivative · entry 3 Garrow Ronald E · CIK 0001573297 · Chief Human Resources Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,954 F2 · shares: The transactions reported in this Form were effected pursuant to a pre-planned trading plan entered into in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934 and previously referenced in a MasterCard Incorporated Form 8-K filed on March 17, 2014. The pre-planned trading plan was adopted by the reporting person on March 12, 2014. Read SEC document |
| October 30, 2014 Filed Nov 3, 2014 22:02 UTC | Mastercard Inc MA · Entity 1763 | Exercise / conversionClass A Common Stock | 3,550 | $51.83 | $183,996.50 |
DisclosureSEC source: 0001225208-14-022464 · doc4.xml · nonDerivative · entry 2 Garrow Ronald E · CIK 0001573297 · Chief Human Resources Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,724 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · shares: The transactions reported in this Form were effected pursuant to a pre-planned trading plan entered into in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934 and previously referenced in a MasterCard Incorporated Form 8-K filed on March 17, 2014. The pre-planned trading plan was adopted by the reporting person on March 12, 2014. Read SEC document |
| October 30, 2014 Filed Nov 3, 2014 22:02 UTC | Mastercard Inc MA · Entity 1763 | Exercise / conversionClass A Common Stock | 4,220 | $42.04 | $177,421.46 |
DisclosureSEC source: 0001225208-14-022464 · doc4.xml · nonDerivative · entry 1 Garrow Ronald E · CIK 0001573297 · Chief Human Resources Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,174 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: The exercise price for the reporting person's employee stock options awarded on March 1, 2012 has been changed from $42.0330 to $42.0430. This is intended to correct an administrative error in Column 4 of Table II (Derivative Securities Beneficially Owned) on the reporting person's Form 3 filed on April 2, 2013. Read SEC document |
| March 01, 2014 Filed Mar 4, 2014 23:44 UTC | Mastercard Inc MA · Entity 1763 | GrantEmployee Stock Option (right to buy) · Derivative | 17,496 | $0.00 Strike: $77.72 | $0.00 |
DisclosureSEC source: 0001225208-14-007385 · doc4.xml · derivative · entry 2 Garrow Ronald E · CIK 0001573297 · Chief Human Resources Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,496 Underlying: Class A Common Stock · 17,496 shares Expires 2024-03-01 F3 · derivative.exercise_date: The employee stock options vest in four equal annual installments beginning March 1, 2015. Read SEC document |
| February 28, 2014 Filed Mar 4, 2014 23:44 UTC | Mastercard Inc MA · Entity 1763 | Tax withholdingClass A Common Stock | 2,696 | $77.81 | $209,774.41 |
DisclosureSEC source: 0001225208-14-007385 · doc4.xml · nonDerivative · entry 1 Garrow Ronald E · CIK 0001573297 · Chief Human Resources Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,954 F1 · shares: Represents withholding of shares to pay tax liability incident to the vesting of restricted stock units pursuant to the terms of a shareholder-approved stock plan. This amount refects the ten-for-one stock split of the Company's common stock, which was effected in the form of a stock dividend distributed on January 21, 2014. F2 · balance_after: This amount reflects the ten-for-one stock split of the Company's common stock, which was effected in the form of a stock dividend distributed on January 21, 2014. Read SEC document |
| April 08, 2013 Filed Apr 10, 2013 21:01 UTC | Mastercard Inc MA · Entity 1763 | Disposition to issuerClass A Common Stock | 546 | $530.69 | $289,756.74 |
DisclosureSEC source: 0001225208-13-009887 · doc4.xml · nonDerivative · entry 1 Garrow Ronald E · CIK 0001573297 · Chief Human Resources Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,365 F1 · shares: The transactions reported in this Form 4 were effected pursuant to a pre-planned trading plan entered into in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934. The pre-planned trading plan was adopted by the reporting person on February 5, 2013, with sales expected between April 8, 2013 and October 8, 2013. The transactions reported in this Form 4 constitute the entire amount of shares to be sold pursuant to the plan. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.